OppenheimerFunds’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $19.4M | Buy |
383,787
+10,804
| +3% | +$546K | 0.02% | 547 |
|
|
2018
Q4 | $22.1M | Buy |
372,983
+18,423
| +5% | +$1.09M | 0.03% | 475 |
|
|
2018
Q3 | $23.3M | Buy |
354,560
+12,970
| +4% | +$854K | 0.03% | 548 |
|
|
2018
Q2 | $17.2M | Buy |
341,590
+8,507
| +3% | +$430K | 0.02% | 613 |
|
|
2018
Q1 | $17.5M | Buy |
333,083
+1,325
| +0.4% | +$69.8K | 0.02% | 597 |
|
|
2017
Q4 | $15.4M | Buy |
331,758
+321,918
| +3,272% | +$15M | 0.02% | 661 |
|
|
2017
Q3 | $398K | Sell |
9,840
-2,631
| -21% | -$106K | ﹤0.01% | 1610 |
|
|
2017
Q2 | $422K | Sell |
12,471
-87
| -0.7% | -$2.94K | ﹤0.01% | 1582 |
|
|
2017
Q1 | $364K | Buy |
12,558
+2,351
| +23% | +$68.1K | ﹤0.01% | 1633 |
|
|
2016
Q4 | $335K | Buy |
10,207
+923
| +10% | +$30.3K | ﹤0.01% | 1561 |
|
|
2016
Q3 | $293K | Buy |
+9,284
| New | +$293K | ﹤0.01% | 1502 |
|
|
2016
Q2 | – | Sell |
-6,706
| Closed | -$244K | – | 1709 |
|
|
2016
Q1 | $244K | Sell |
6,706
-1,013
| -13% | -$36.9K | ﹤0.01% | 1529 |
|
|
2015
Q4 | $309K | Buy |
+7,719
| New | +$309K | ﹤0.01% | 1500 |
|